clinical trials

Only hospitals approved by experts’ panel are allowed to offer treatment

Hydroxychloroquine is a drug that scientists were optimistic will show improved symptoms for patients with COVID-19

Tocilizumab, with the common brand name Actemra, has been included in China's latest version of diagnosis

Rolf Hilgenfeld and his team have been devoted to research of SARS-CoV inhibitors for many years, says Chinese media